Xilio Therapeutics, Inc. (XLO)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
9. 02
+0.12
+1.3483%
$
59.51M Market Cap
- P/E Ratio
- Div Yield
10,368 Volume
-1.47 Eps
$ 8.9
Previous Close Want to track XLO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xilio Therapeutics, Inc. (XLO) Statistics
Valuation metrics
Market Cap 59.51M
Enterprise value -70.23M
Trailing P/E (ttm) -6.07
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) 0.93
Price/Book (mrq) 2.43
Enterprise Value/Revenue -1.1
Enterprise Value/EBITDA 3.43
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.5K
Average volume (90 days) 12.11K
Price summary
52-Week low 6.47
52-Week high 12.59
Beta -
50-Day moving average 8.94
200-Day moving average 8.41
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:14
Last split Date 16 Mar 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.34%
Operating margin -0.49%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.51%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.3
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.12
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0.09
Current ratio (mrq) 4.25%
Book value per share (mrq) 3.72
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
